Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 201-579-4 | CAS number: 85-00-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- Sep 1990 to Dec 1990
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
- Objective of study:
- distribution
- excretion
- metabolism
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 417 (Toxicokinetics)
- GLP compliance:
- yes
Test material
- Reference substance name:
- 6,7-dihydrodipyrido[1,2-b:1',2'-e]pyrazine-5,8-diium;dibromide;hydrate
- Cas Number:
- 6385-62-2
- Molecular formula:
- C12H12N2.2Br.H2O
- IUPAC Name:
- 6,7-dihydrodipyrido[1,2-b:1',2'-e]pyrazine-5,8-diium;dibromide;hydrate
Constituent 1
- Radiolabelling:
- yes
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Age at study initiation: males ca 50 days; females ca 60 days
- Housing: after dosing: plastic metabowls designed for the separate collection of urine and faeces
- Diet: standard laboratory diet, ad libitum
- Water: ad libitum
- Acclimation period: ca 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21 ± 3
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Radiolabelled [14C]-test substance (ca 24.7 MB) and non-radiolabelled test material monohydrate (1088.15 mg) were combined in aqueous solution (ca 25 g) in a plastic container. The concentration of radioactivity was measured and the specific activity was calculated to be 0.044 MBq/mg test material ion. Samples of the dose solution were weighed and analysed for total radioactivity. Individual doses were administered orally by gavage. The dose received by animals was assessed from the weight of the dose syringe and contents before administration and weight of dose syringe after administration. - Duration and frequency of treatment / exposure:
- Single dose
Doses / concentrations
- Dose / conc.:
- 1 mg/kg bw (total dose)
- No. of animals per sex per dose / concentration:
- 5
- Control animals:
- no
- Positive control reference chemical:
- None
- Details on dosing and sampling:
- TOXICOKINETIC / PHARMACOKINETIC STUDY
- Following administration the rats were placed in plastic metabowls designed for the separate collection of urine and faeces.
- Tissues and body fluids sampled: urine, faeces, final cage wash
- Urine was collected at 8, 24, 36, 48, 72, 96, 120, 144 and 168 h post dose.
- Faeces were collected at 24, 48, 72, 96, 120, 144 and 168 h.
- Cages were rinsed at 24 h and daily thereafter, and a final cage wash was made after the last collection.
- Urine and faeces were collected into containers cooled with solid CO2 for the first 48 h post dose.
- At termination the animals were killed by CO2 narcosis an the following tissues, organs and body fluids were removed for analysis: bone, brain, testes/ovaries, stomach, stomach contents, small intestine, small intestine contents, large intestine, large intestine contents, plasma, whole blood, fat, heart, kidney, liver, lens, lungs muscle, spleen
- Total radioactivity was measured in urine, faeces, cage wash, tissues, organs, body fluids and remaining carcass.
Results and discussion
Main ADME resultsopen allclose all
- Type:
- excretion
- Results:
- A mean of 85.5% of administered radioactivity was recovered in the faeces by 168 h post dose. Excretion via urine accounted for a mean of 5.4% of the dose administered. The mean total administered radioactivity recovered was 93.2%
- Type:
- distribution
- Results:
- Total radioactivity in tissues, organs and body fluids was close to background. Highest levels were detected in the organs of excretion, kidney and liver (mean of 0.076 and 0.036 µg equiv /g respectively)
- Type:
- metabolism
- Results:
- Radio-TLC analysis of pooled urine samples (0-48 h post dose; male and female separately) indicated the presence of a single major radiolabelled component of similar retention factor (Rf) to [14C]-test substance.
- Type:
- metabolism
- Results:
- Radio-TLC analysis of extracts of pooled faeces (0-72 h post dose; male and female separately) indicated the presence of a single radiocomponent of a similar chromatographic character to [14C]-test substance
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- An oral dose of the test substance was apparently poorly absorbed in the rat. Following single oral administration of [14C]-test substance to rats at a target dose level of 186.8 mg/kg a mean of 5.4% of the administered radioactivity was recovered in the urine, and most of the radiolabelled material was recovered in faeces.
- Details on excretion:
- There was no sex difference in the pattern of excretion.
Metabolite characterisation studies
- Metabolites identified:
- no
- Details on metabolites:
- Radio-TLC analysis of pooled urine samples (0-48 h post dose; male and female separately) indicated the presence of a single major radiolabelled component of similar retention factor (Rf) to [14C]-test substance.
Radio-TLC analysis of extracts of pooled faeces (0-72 h post dose; male and female separately) indicated the presence of a single radiocomponent of a similar chromatographic character to [14C]-test substance
Any other information on results incl. tables
Table 1. Cumulative Excretion of Total Radioactivity in Excreta Following Single Oral Administration [14C]-test substance. Results expressed as % administered dose recovered
Sample/Time (h) |
Males |
Females |
||||||||||
1 |
2 |
3 |
4 |
5 |
Mean |
1 |
2 |
3 |
4 |
5 |
Mean |
|
Urine |
||||||||||||
0 – 8 |
0.77 |
1.62 |
1.13 |
0.9 |
1.04 |
1.09 |
1.05 |
1.27 |
1.18 |
0.72 |
1.31 |
1.11 |
0 – 24 |
1.91 |
3.24 |
3.28 |
2.74 |
3.56 |
2.94 |
2.07 |
2.68 |
4.62 |
2.21 |
2.41 |
2.79 |
0 – 36 |
2.69 |
4.59 |
4.37 |
4.06 |
3.74 |
3.89 |
2.92 |
3.34 |
5.75 |
3.15 |
3.02 |
3.64 |
0 – 48
|
3.12 |
9.27 |
5.22 |
4.9 |
4.03 |
5.31 |
4.12 |
3.88 |
7.94 |
4.5 |
3.44 |
4.78 |
0 - 72 |
3.25 |
10.75 |
5.3 |
5 |
4.07 |
5.57 |
4.29 |
4.01 |
8.09 |
4.57 |
4.16 |
5.02 |
0 - 98 |
3.27 |
10.78 |
5.31 |
5.01 |
4.07 |
5.59 |
4.32 |
4.03 |
8.13 |
4.59 |
4.28 |
5.07 |
0 – 120 |
3.28 |
10.79 |
5.32 |
5.02 |
4.07 |
5.7 |
4.33 |
4.04 |
8.15 |
4.6 |
4.37 |
5.1 |
0 – 144 |
3.28 |
10.80 |
5.33 |
5.02 |
4.07 |
5.7 |
4.35 |
4.04 |
8.15 |
4.6 |
4.39 |
5.11 |
0 – 168 |
3.28 |
10.80 |
5.33 |
5.02 |
4.07 |
5.7 |
4.35 |
4.04 |
8.15 |
4.6 |
4.4 |
5.11 |
Faeces |
||||||||||||
0 – 24 |
61.73 |
25.45 |
28.34 |
38.08 |
63.61 |
43.44 |
42.19 |
25.28 |
31.1 |
26.58 |
24.63 |
30.16 |
0 - 48 |
85.66 |
61.57 |
73.67 |
79.20 |
85.01 |
77.02 |
83.74 |
73.55 |
67.27 |
68.61 |
54.55 |
69.54 |
0 – 72 |
88.83 |
82.22 |
75.37 |
83.59 |
86.50 |
82.90 |
89.1 |
85.57 |
79.89 |
83.67 |
73.75 |
82.4 |
0 – 96 |
88.19 |
84.17 |
75.62 |
84.10 |
86.89 |
83.80 |
90.68 |
86.07 |
82.38 |
86.49 |
80.59 |
85.24 |
0 – 120 |
88.25 |
84.58 |
75.63 |
84.96 |
85.95 |
84.08 |
91.1 |
86.11 |
82.92 |
86.62 |
86.12 |
86.57 |
0 – 144 |
88.27 |
84.69 |
75.65 |
84.97 |
86.99 |
84.11 |
91.28 |
86.13* |
83 |
86.65 |
86.9 |
86.79 |
0 – 168 |
88.45 |
84.75 |
75.65 |
84.97 |
87.04 |
84.17 |
91.29 |
86.15 |
83.01* |
86.67 |
87.05 |
86.83 |
Cage wash |
||||||||||||
0 – 24 |
0.28 |
0.83 |
8.7 |
1.39 |
1.54 |
2.55 |
0.81 |
1.37 |
3.94 |
0.45 |
0.39 |
1.39 |
0 - 48 |
0.39 |
1.1 |
8.92 |
1.48 |
1.62 |
2.7 |
0.89 |
1.54 |
4.01 |
0.56 |
0.56 |
1.52 |
0 – 72 |
0.41 |
1.28 |
8.97 |
1.63 |
1.63* |
2.78 |
0.93* |
1.6 |
4.07 |
0.63* |
0.67 |
1.58 |
0 – 96 |
0.45* |
1.28** |
8.98** |
1.64* |
1.64** |
2.80 |
0.95** |
1.61** |
4.10* |
0.67 |
0.7* |
1.61 |
0 – 120 |
0.45** |
1.28** |
8.98** |
1.54** |
1.64** |
2.80 |
0.95** |
1.61** |
4.10** |
0.67** |
0.75 |
1.62 |
0 – 144 |
0.45** |
1.28** |
8.98** |
1.64** |
1.64** |
2.80 |
0.95** |
1.61** |
4.10** |
0.68** |
0.77* |
1.62 |
0 – 168 |
0.46** |
1.32 |
8.98** |
1.66** |
2.08 |
2.9 |
1 |
1.66 |
4.2 |
0.73 |
0.95 |
1.71 |
Total excreta |
||||||||||||
0 – 8 |
1.05 |
2.45 |
9.83 |
2.29 |
2.57 |
3.64 |
1.86 |
2.64 |
5.12 |
1.17 |
1.7 |
2.5 |
0 – 24 |
63.91 |
29.52 |
40.32 |
42.21 |
68.7 |
48.93 |
45.07 |
30.31 |
39.66 |
29.24 |
27.43 |
34.34 |
0 – 36 |
64.69 |
30.87 |
41.41 |
43.53 |
68.88 |
49.88 |
45.92 |
30.99 |
40.79 |
30.18 |
28.04 |
35.18 |
0 – 48 |
89.17 |
71.94 |
87.81 |
85.58 |
90.66 |
85.03 |
88.75 |
78.98 |
79.22 |
73.7 |
58.55 |
75.84 |
0 – 72 |
90.49 |
94.25 |
89.64 |
90.22 |
92.2 |
91.36 |
94.32 |
91.18 |
92.05 |
88.87 |
78.58 |
89 |
0 – 96 |
91.91 |
96.23 |
89.91 |
90.75 |
92.61 |
92.28 |
95.95 |
91.71 |
94.61 |
91.75 |
85.57 |
91.92 |
0 – 120 |
91.98 |
96.65 |
89.93 |
91.62 |
92.68 |
92.57 |
96.38 |
91.76 |
95.17 |
91.89 |
91.24 |
93.29 |
0 – 144 |
92 |
96.77 |
89.96 |
91.63 |
92.71 |
92.62 |
96.58 |
91.78 |
95.25 |
91.93 |
92.06 |
93.52 |
0 – 168 |
92.19 |
96.87 |
89.96 |
91.65 |
93.2 |
92.78 |
96.64 |
91.85 |
95.36 |
92.01 |
92.4 |
93.65 |
Tissues |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Carcass |
0.03** |
0** |
0.04** |
0.03** |
0.01** |
0.02 |
0** |
0** |
0.02** |
0.01** |
0** |
0.01 |
Total recovered |
92.22
|
96.87 |
90 |
91.68 |
93.21 |
92.78 |
96.64 |
91.85 |
95.38 |
92.02 |
92.40 |
93.66 |
* results derived from data <30 d.p.m. above background
** results derived from data <10 d.p.m above background
Applicant's summary and conclusion
- Conclusions:
- An oral dose of diquat was apparently poorly absorbed in the rat. Following single oral administration of the [14C]-test substance to rats at a target dose level of 100 mg/kg test substance a mean of 5.4% of administered radioactivity was recovered in urine, and most of the radiolabelled material was recovered in faeces. The relatively low levels of radioactivity in tissues tat 168 h post dose and the presence of parent compound in extracts of pooled faeces are consistent with limited absorption of the test substance. the chromatographic profiles of pooled urine samples indicated that the low proportion of radiolabelled material absorbed is excreted unmetabolized.
A mean of 73.3% of administered radioactivity was recovered in the faeces by 48 h; by 168 h post dose the mean faecal recovery was 85.5%. Excretion by the urinary route accounted for 5.4% of the administered dose by 168 h. The mean total dose recovered was 93.2%. At 168 h post dose levels of radioactivity in tissues, organs and body fluids were at, or close to, background. - Executive summary:
This report describes aspects of the elimination of [14C]-test substance in the rat following single oral administration at a target dose level of 186.8 mg/kg. Radioactivity was predominantly excreted via faeces. A mean of 73.3% of administered radioactivity was recovered in the faeces by 48 h; by 168 h post dose the mean faecal recovery was 85.5%. Excretion by the urinary route accounted for 5.4% of the administered dose by 168 h. The mean total dose recovered was 93.2%. At 168 h post dose levels of radioactivity in tissues, organs and body fluids were at, or close to, background. No apparent sex difference was observed in the pattern of excretion. Radio-TLC analysis of pooled urine samples indicated the presence of a single major radiocomponent which co-chromatographed with [14C]-test substance. A similar component was observed in the extract of pooled faeces samples.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)